Background. We sought to elaborate the epidemiology and outcomes of adult patients with occult Staphylococcus aureus bacteremia who were inadvertently discharged from the emergency department (ED) before positive blood culture results were obtained.
Bacteremia, the existence of bacteria circulating in bloodstream, usually indicates the presence of a systemic and serious disease that requires aggressive treatment and further investigation [1] [2] [3] . Even with significant progress in modern medical technologies, blood culture remains the standard microbiological test for detecting bacteremia, providing final bacterial identification, and determining antimicrobial susceptibility. However, it often takes 24-48 hours of in vitro incubation for bacterial populations to reach a size detectable by standard laboratory equipment [4] . As a consequence, the blood culture results are never available for immediate decisions regarding patient disposition in the emergency department (ED). A bacteremia patient might therefore be inadvertently discharged by an ED physician when the patient does not have any indications for hospital admission and a bacteremia diagnosis is not anticipated. This raises a serious concern that delayed recognition and treatment of bacteremia in these patients may result in worsened clinical outcomes compared with those bacteremia patients who are treated and hospitalized at the time of their ED visit. Bacteremia patients who are discharged directly from EDs are therefore an important patient safety issue in the field of emergency medicine [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] .
Previous studies addressing this special issue mainly focused on pediatric patients [5] [6] [7] [8] [9] [10] [11] [12] . Very few studies have shed light on the epidemiology and clinical outcome of patients with occult bacteremia in the adult population [13] [14] [15] [16] . Although researchers have previously suggested that these adult occult bacteremia patients can be safely recalled for reevaluation and treatment, their studies were limited either by small sample sizes [13, 15] , inclusion of pediatric patients [15] , or missing information about the final outcome after subsequent hospitalization or out-patient department (OPD) treatment [13] [14] [15] [16] . Because Staphylococcus aureus bacteremia tends to be complicated by endovascular, deep-seated, and metastatic infections and requires prolonged antimicrobial therapy [17] [18] [19] [20] , it is plausible that occult S. aureus bacteremia patients might have poorer clinical outcomes than occult bacteremia patients with other bacterial infections. Similarly, the inadvertent discharge of Staphylococcus aureus bacteremia patients from EDs might adversely impact their clinical outcome due to delayed comprehensive evaluation and antimicrobial therapy when compared with S. aureus bacteremia patients who were directly hospitalized at the time of their first ED visit. However, there are no studies that specifically elaborate the impact of occult S. aureus bacteremia on patient outcome based on these 2 perspectives.
In this study, we proposed 2 hypotheses. First, we hypothesized that occult S. aureus bacteremia patients had higher decision-contributed mortality than directly hospitalized S. aureus bacteremia patients due to delayed evaluation and treatment. Second, we hypothesized that occult S. aureus bacteremia patients had higher disease-associated mortality than occult bacteremia patients with other bacterial infections due to endogenous virulence or the infection pattern associated with S. aureus. To test our hypotheses, we conducted two 1:2 case-control studies to specifically evaluate the impact of occult S. aureus bacteremia on patient outcome.
METHODS

Hospital Setting and Management Strategy
This retrospective study was conducted in the ED of the National Taiwan University Hospital. This 2500-bed, universityaffiliated teaching hospital provides primary, secondary, and tertiary care in northern Taiwan in its departments, covering all major specialties, including transplantation and oncology. The ED of this hospital has an average of 100 000 visits annually. A central microbiology laboratory is responsible for the management of all clinical specimens. Since 2001 when the laboratory began detecting bacterial growth in incubated blood culture bottles, positive results have been reported by telephone to the attending physicians before the results of final bacterial identification and antimicrobial susceptibility testing becomes available. If the patient has been discharged from the ED, the laboratory technician notifies the ED administrative office immediately, as a patient safety protection mechanism. A senior ED resident then contacts the patient or his/her family by telephone and requests the patient return to the ED for reevaluation and treatment. If the patient has become afebrile and free of clinical symptoms after ED discharge and refuses to return to the ED, OPD follow-up is arranged as soon as possible. For patients who have been admitted to another hospital, tentative and final blood culture results for that patient are forwarded to the admitting hospital and a follow-up telephone interview is conducted 1 month after the index blood culture.
Study Design and Patient Selection
This study retrospectively reviewed the records of all adult patients ($15 years of age) between 1 January 2001 and 31 December 2010 who had positive blood culture results that were reported after they were discharged from the ED. Patients were considered to have true bacteremia if $2 sets of blood cultures collected from separate sites grew the same bacteria or a single blood culture grew pathogenic bacteria and was from a patient with compatible clinical manifestations. Coagulase-negative staphylococci and other common skin flora isolated in a single blood culture were considered to be contaminated when they occurred in the absence of a compatible clinical picture and predisposing risk [21, 22] . The ''occult bacteremia'' patients in this study were patients whose blood cultures were finally determined to be true bacteremia but who were discharged from the ED prior to the availability of blood culture results. The case group consisted of all occult bacteremia patients with blood culture isolates of S. aureus for whom follow-up records were available.
We performed two 1:2 case-control studies based on our study hypotheses. In the first case-control study, each case group patient was matched individually to 2 control patients with S. aureus bacteremia who had been directly admitted to the hospital at the time of their initial ED visit (control group I). We retrieved the ED S. aureus bacteremia patient list and clinical data from our longitudinal prospective study of community-onset S. aureus bacteremia, as published elsewhere [23] [24] [25] . Patients in control group 1 were matched to those in the case group on the basis of Charlson comorbidity index, sepsis severity, and category of the primary infection site (infection sites were matched on the basis of category and were not necessarily identical; eg, pneumonia might be matched with empyema, psoas abscess with pyomyositis of the thigh, etc). In the second case-control study, each case group patient was matched to the 2 patients with the nearest culture date who had occult bacteremia from bacteria other than S. aureus
(control group II). This study was approved by the institutional review board of the hospital, and a waiver of informed consent was obtained from each patient.
Data Collection and Outcome Variables
Patient data, including demographic information, comorbidity, Charlson comorbidity score, sepsis severity, empirical antimicrobial therapy, and the final result of the index blood culture at the time of the ED visit, was recorded for all case and control group patients. Judgments of the effectiveness of empirical antimicrobial therapy provided at the first ED visit were based on the results of in vitro susceptibility tests of blood culture isolates. Primary infection sites and any hospitalizations or OPD treatment courses were determined from medical records. For occult bacteremia patients who received initial treatment at OPDs, any subsequent hospitalization for antimicrobial therapy within 1 month of the initial ED visit was considered to be related to the index bacteremia event. The primary outcome in this study was 30-day survival status. The secondary outcomes included the rates of hospital admission, intensive care unit (ICU) admission, organ failure, septic shock, and the duration of ICU and hospital stays relating to the index bacteremia event.
Statistical Analysis
Nonparametric Spearman rank correlation coefficient was used to compare the number of annual adult ED patients and blood culture with the incidence of occult bacteremia (episodes per 100 000 adult ED visits). An independent Student t test was used to compare continuous variables, whereas categorical variables were analyzed with v 2 or Fisher exact tests. The 30-day survival curves of the study groups were created using the Kaplan-Meier method. Differences in cumulative survival were tested by Wilcoxon rank sum tests. Independent factors for mortality were investigated by forward, backward, and manual Cox regression modeling. Data were analyzed with SPSS software for Windows (release 16.0; SPSS, Chicago, IL).
RESULTS
From 1 January 2001, through 31
December 2010, bacteremia blood culture results were reported as positive for a total of 1256 adult patients after they had been discharged from the ED (Table 1 ). Of these, 759 patients, including 65 patients with S. aureus bacteremia, had true bacteremia. Escherichia coli was the predominant bloodstream isolate and accounted for 36.8% (296 of 805) of all isolates. The annual incidence of occult bacteremia during the 10-year study period is shown in Figure 1 . The incidence of occult bacteremia correlated with the annual ED blood culture number (Spearman q, 0.794; (12), Campylobacter species (7), Hemophilus influenzae, non-type B (4), Vibrio species (3), Sphingomonas paucimobilis (2), Moraxella species (2), Burkholderia species (2), Comamonas testosteroni (1), Neisseria cinerea (1), Pantoea agglomerans (1), and Roseomonas species (1). e Includes group B streptococcus (29), group A streptococcus (7), group G streptococcus (6), group C streptococcus (5), and group F streptococcus (2). f Includes Enterococcus faecalis (12), E. faecium (5), E. casseliflavus (3), and E. gallinarum (1). g Includes Arcanobacterium haemolyticum (1) and Gemella haemolysans (1).
h Includes Fusobacterium species (5), Lactobacillus species (4), Abiotrophia defective (2), Eikenella corrodens (1), Bilophila wadsworthia (1), Porphyromonas asaccharolytica (1), Veillonella species (1) and un-identified anaerobic bacteria (1). P 5 .006) but did not correlate with the annual number of adult ED patients (Spearman q, 0.055; P 5 .881).
Among the 65 occult S. aureus bacteremia patients, 3 patients were lost to follow-up and were excluded from the final analysis. The remaining 62 occult S. aureus bacteremia patients constituted the case group, and each was matched with 2 directly hospitalized S. aureus bacteremia patients (control group I) and 2 occult bacteremia patients with other bacterial infections (control group II). In control group II, a total of 131 isolates were identified, and 7 of the 124 patients had polymicrobial infections (Table 2 ). With the exception of S. aureus, there was no difference in the distribution of major bacterial types between control group II patients and the total population of occult bacteremia patients.
Comparisons of the clinical characteristics and outcome variables between the case group and each control group are presented in Table 3 . Compared to control group I, the case group had significantly lower percentage of prior cardiovascular accident history (4.8% vs 14.5%; P 5 .049) and receiving effective empirical antimicrobial therapy at the time of first ED visit (56.5% vs 71.8%; P 5 .037). The case group and control group I did not differ in any outcome variable except final hospitalization rate (77.4% vs 100%; P , .001). In the case group, the patients were younger, and there were more male patients than in control group II (P , .05 for both). The case group also contained more patients with end-stage renal disease, central vascular catheter placement, and high Charlson score than control group II (all P , .05). Compared with control group II, the case group had a significantly higher percentage of hospital and ICU admissions, organ failure, septic shock, metastatic infection foci, and 30-day mortality (all P , .05). Case group patients also had significantly longer hospital stays than control group II patients (P , .05).
The Kaplan-Meier survival curves for the 3 patient groups are shown in Figure 2 . The 30-day cumulative probabilities of survival for the case group, control group I, and control group II were 90%, 90%, and 98%, respectively (P 5 .019, by Wilcoxon rank sum test). Table 4 
DISCUSSION
In this study, we specifically evaluated the impact of S. aureus infection on various clinical outcomes of occult bacteremia in adult patients who were discharged from the ED before positive blood culture results were available. We found that there was no evidence that mortality was higher for occult S. aureus bacteremia patients than for S. aureus bacteremia patients who were directly hospitalized at the time of their first ED visit. However, adverse outcomes occurred more often for occult S. aureus bacteremia than for occult bacteremia patients with other bacterial infections. Although occult S. aureus bacteremia is a rare occurrence, it is crucial that clinicians recognize this important clinical issue in adult ED patients in order to improve patient safety and clinical outcomes.
The discharge of bacteremia patients from EDs before blood culture results are available is a clinical problem that has been well recognized for more than 4 decades. Initial studies of the problem focused primarily on pediatric patients, and bacteremia diagnosed after ED discharge was often called ''occult bacteremia'' because the febrile pediatric patients involved were previously healthy, appeared to be well, and had no identifiable infection focus at the time of initial evaluation [5-7, 9-12, 26, 27] . Most pediatric patients with occult bacteremia were ,3 years of age [5] [6] [7] [8] [9] [10] [11] [12] . In most of these studies, Streptococcus pneumoniae accounted for the majority (54%-82.9%) of blood culture isolates, followed by Salmonella species, group A Streptococcus, and Haemophilus influenzae (not type B) [9, 11, 12, 15] . In contrast, as observed previously [15, 16] and in this study, occult bacteremia in adult patients had a wider age distribution and more diverse microbial etiologies than reported in studies of pediatric patients. Escherichia coli, Klebsiella pneumoniae, S. aureus, and viridian Streptococcus accounted for approximately 70% of total bloodstream isolates from adult patients with occult bacteremia. Many of these adult bacteremia patients had an underlying comorbid medical condition and an obvious infection focus at the time of their ED visit [14] [15] [16] . It is therefore reasonable to consider occult bacteremia in adult patients as a distinct entity from occult bacteremia in pediatric patients.
There are several patient safety concerns in the management of occult bacteremia patients. Between 33.7% and 57% of adult occult bacteremia patients do not receive effective empirical antimicrobial agents after their initial ED visit. Among occult bacteremia patients who return to the ED for reevaluation, 44.5%-65% of them receive a different diagnosis and 14%-82.4% of them require hospital admission [15, 16] . Delays in hospitalization may prevent early diagnosis of infection foci that require surgical intervention for sepsis control, such as deep-seated abscesses or endovascular infections. However, it is difficult to evaluate effects on clinical outcome that are attributable solely to such delays. In clinical practice, ED physicians typically use a combination of clinical diagnosis and a variety of severity indices, rather than the probability of bacteremia, to determine whether to admit or discharge a patient. Ambulatory patients with lower disease severity who are at low risk for mortality tend to be discharged from the ED and referred to an OPD for treatment. These factors might confound our observations, making it difficult to conclude that discharging an occult bacteremia patient causes an undesirable outcome. In this study, we compared occult S. aureus bacteremia cases with cases of S. aureus that were directly hospitalized from the ED that had equivalent disease severity and infection focus. Our results showed no difference between these 2 groups in any of the outcome variables, even though a higher percentage of occult S. aureus bacteremia patients did not receive effective empirical antimicrobial therapy at the time of their first ED visit. Our first hypothesis-that the discharge of patients with occult S. aureus bacteremia from the ED would lead to poorer clinical outcomes-was therefore not supported. One possible explanation for this result is that the occult S. aureus bacteremia patients in this study were in the early stage of sepsis at the time of their ED visit. Alternatively, these patients might have had S. aureus infections that were endogenously benign in their clinical course, regardless of OPD or hospital treatment. The relative early or benign clinical course buffered the potential impact of delayed treatment and hospitalization for these bacteremia patients. Three previous studies have reported low mortality rates, ranging from 0% to 3.7%, for adult occult bacteremia patients. Ramos et al [16] reported that 4 of 107 (3.7%) occult bacteremia patients died. Two of them were due to endocarditis. None of these studies described the causative bacteriology of their mortality cases. Although we appreciate the low risk of mortality among all occult bacteremia patients, we found a significant mortality rate among patients with S. aureus bloodstream infections (30-day mortality, 9.7%). Further, Cox regression analysis identified age, endovascular infection, and S. aureus infection as independent predictors of mortality for patients with occult bacteremia. The effect on mortality from S. aureus infection was independent of patients' underlying disease severity, even after the Charlson comorbidity score was forced into the Cox the regression model. Because S. aureus has become an important pathogen in community-acquired infections, patients with occult S. aureus bacteremia may also seek treatment at out-patient clinics. First-line clinicians should recognize the possibility of S. aureus infection in managing sepsis patients, particularly for patients without an apparent infection focus. There are limitations in this study. First, the criteria employed for determining whether positive blood culture results were due to contamination might differ from other studies of adult occult bacteremia. Such differences make comparisons of bacteriology and incidences between studies difficult. Second, because we specifically evaluated the impact of occult S. aureus bacteremia on patient outcome using a case-control study design, we did not collect clinical data for all adult occult bacteremia patients and are therefore unable to provide the mortality rate for those patients. Finally, this analysis was limited by its retrospective nature and is therefore subject to information bias.
In summary, on the basis of significant differences in demography, clinical characteristics, bacteriology, and outcome, occult bacteremia in adult patients is a distinct disease entity from occult bacteremia in pediatric patients. Occult S. aureus bacteremia patients did not have worse clinical outcomes than S. aureus bacteremia patients who were directly hospitalized at the time of their initial ED visit. This implies occult bacteremia infections were either at an early stage of sepsis when patients first visited the ED or were endogenously benign in their clinical course. However, among adult patients with occult bacteremia, S. aureus infections had a significant adverse impact on mortality, compared with other bacterial infections. Because S. aureus bacteremia is frequently associated with endovascular or deep-seated infection, prudent evaluation of patients without an apparent infection focus is imperative for first-line clinicians before discharging febrile patients from EDs or out-patient clinics. 
Notes
